Abstract: A catalyst and process is disclosed to selectively upgrade a paraffinic feedstock to obtain an isoparaffin-rich product for blending into gasoline. The catalyst comprises a support of a sulfated oxide or hydroxide of a Group IVB (IUPAC 4) metal, a first component of at least one lanthanide element or yttrium component, which is preferably ytterbium, and at least one platinum-group metal component which is preferably platinum and a refractory-oxide binder having at least one platinum-group metal component dispersed thereon.

Abstract: This invention provides a compact heat exchanger that has an effective geometry for heat transfer operations regardless of the heat conductivity of the material chosen for the fin materials. It has further been found that the use of adsorbent coated anodized aluminum for fin materials provides for a very efficient heat exchanger.

Abstract: A phase shift measurement system comprises an excitation system, a luminescent material, and a detection system. The excitation system transfers an excitation light wave. The luminescent material transfers a luminescent light wave in response to the excitation light wave. The detection system detects the luminescent light wave and generates a corresponding luminescent signal. The detection system processes the corresponding luminescent signal with DFT logic to determine a phase shift between the excitation light wave and the luminescent light wave.

Abstract: A fire suppression system for producing an inert gas mixture having a minimal amount of carbon monoxide, particulates, or smoke. The inert gas mixture may be generated by combusting a gas generant. The gas generant may be a composition that includes hexa(ammine)-cobalt(III)-nitrate. The fire suppression system also includes a heat management system to reduce a temperature of the inert gas mixture. A method of extinguishing fires is also disclosed.

Abstract: A method for treating attention deficit/hyperactivity disorder (ADHD) includes performing an objective ADHD behavioral assay for a patient, administering a drug to the patient at varying doses, and performing an fMRI on the patient for the varying drug doses to determine an optimal dosage for the patient. The method can further include performing a further objective ADHD behavioral assay after the drug administration.

Abstract: A family of visors for automotive vehicles includes a plurality of members. Each member of the family includes at least some degree of commonality and preferably some degree of difference with one or more members of the family.

Abstract: This invention provides a compact heat exchanger that has an effective geometry for heat transfer operations regardless of the heat conductivity of the material chosen for the fin materials. It has further been found that the use of adsorbent coated anodized aluminum for fin materials provides for a very efficient heat exchanger.

Abstract: A catalyst and process is disclosed to selectively upgrade a paraffinic feedstock to obtain an isoparaffin-rich product for blending into gasoline. The catalyst comprises a support of a sulfated oxide or hydroxide of a Group IVB (IUPAC 4) metal, a first component of at least one lanthanide element or yttrium component, which is preferably ytterbium, and at least one platinum-group metal component which is preferably platinum and a refractory-oxide binder having at least one platinum-group metal component dispersed thereon.

Abstract: This invention provides a compact heat exchanger that has an effective geometry for heat transfer operations regardless of the heat conductivity of the material chosen for the fin materials. It has further been found that the use of adsorbent coated anodized aluminum for fin materials provides for a very efficient heat exchanger.

Abstract: Pharmaceutical compositions are disclosed for the treatment of attention deficit hyperactivity disorder (ADHD). The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an anti-ADHD agent and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.

Abstract: A phase shift measurement system comprises an excitation system, a luminescent material, and a detection system. The excitation system transfers an excitation light wave. The luminescent material transfers a luminescent light wave in response to the excitation light wave. The detection system detects the luminescent light wave and generates a corresponding luminescent signal. The detection system processes the corresponding luminescent signal with DFT logic to determine a phase shift between the excitation light wave and the luminescent light wave.

Abstract: An imaging system employs method of labeling orthogonal images. The method comprises: identifying a primary image taken in a first plane; identifying a plurality of secondary images taken in planes orthogonal to the first plane; associating a label to a point in the primary image; calculating a distance from the point to a line of intersection between the primary image and each secondary image in the plurality of images; and associating the label to a secondary image in the plurality of secondary images having a line of intersection with the primary image closest to the point.

Abstract: A roof framing jig for suspending a plurality of individual roof trusses in a predetermined spacing and orientation so as to facilitate construction of a roof truss assembly. The roof framing jig includes a jig frame, a hoist connection for suspending the jig frame, and a plurality of truss supports secured to the jig frame, where each truss support is adapted to suspend an individual roof truss.

Abstract: A method and apparatus are disclosed for providing fully integrated information processing, management and communication functions in a fully integrated RIS-PACS system for a radiology department/healthcare environment by employing brokerless interface methods to synchronize patient and exam data entities in a radiology information system (RIS) database and a picture archive and communication system (PACS) database within the RIS-PACS system and to generate direct database calls to the RIS and PACS databases. The running of RIS and PACS applications within the RIS-PACS system is initiated from client workstations over a web interface. Information from the databases is accessed by the client workstations. Also, the system may communicate between internal PACS applications and an external RIS system over a HL7-based interface or between internal RIS applications and an external PACS system over a standard medical communications interface such as HL7 and DICOM.

Abstract: Pharmaceutical compositions are disclosed for the treatment of obesity, an overweight condition and compulsive overeating. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an anti-obesity agent or weight loss facilitator or promoter and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.

Abstract: A pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal comprising administration of a nicotine receptor partial agonist or a pharmaceutically acceptable salt thereof; and an acetylcholinesterase inhibitor, butylcholinesterase inhibitor, an estrogenic agent, selective estrogen receptor modulator or muscarinic agonist or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier. The nicotine receptor partial agonist and acetylcholinesterase inhibitor, butylcholinesterase inhibitor, estrogen, selective estrogen receptor modulator or muscarinic agonist are present in amounts that render the composition effective enhancing cognition or in the treatment of diseases of cognitive dysfunction including but not limited to Alzheimer's Disease, mild cognitive impairment, age-related cognitive decline, vascular dementia, Parkinson's disease dementia, Huntington's Disease, Stroke, TBI, AIDS associated dementia and schizophrenia.

Abstract: A method of determining an optimal drug dosage to treat a physiological condition includes objectively determining in a patient the presence and/or level of a physiological condition, such as ADHD, treating the patient with varying doses of the drug, and determining the optimal drug dosage based upon fMRI results.

Abstract: A family of visors for automotive vehicles is disclosed. Each member of the family includes at least some degree of commonality and preferably some degree of difference with one or more members of the family.

Abstract: Pharmaceutical compositions are disclosed for the treatment of attention deficit hyperactivity disorder (ADHD). The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an anti-ADHD agent and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.

Abstract: Pharmaceutical compositions are disclosed for the treatment of obesity, an overweight condition and compulsive overeating. The pharmaceutical compositions are comprised of a therapeutically effective combination of a nicotine receptor partial agonist and an anti-obesity agent or weight loss facilitator or promoter and a pharmaceutically acceptable carrier. The method of using these compounds is also disclosed.